BlossomHill
Beyond's analysis on BlossomHill
- — BlossomHill Therapeutics prices upsized $150 million IPO to fund oncology pipeline amid active biotech listing week
- — BlossomHill Therapeutics prices upsized $150 million IPO amid active biotech offering wave